4130 logo

Genovate Biotechnology Co., Ltd. Stock Price

TPEX:4130 Community·NT$3.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

4130 Share Price Performance

NT$26.70
8.66 (48.01%)
NT$26.70
8.66 (48.01%)
Price NT$26.70

4130 Community Narratives

There are no narratives available yet.

Trending Discussion

No trending discussion available.

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with minimal risk.

1 Risk
0 Rewards

Genovate Biotechnology Co., Ltd. Key Details

NT$471.5m

Revenue

NT$308.5m

Cost of Revenue

NT$163.0m

Gross Profit

NT$172.2m

Other Expenses

-NT$9.2m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.067
34.58%
-1.94%
0%
View Full Analysis

About 4130

Founded
1982
Employees
193
CEO
Chia-Chen Chu
WebsiteView website
www.genovate-bio.com

Genovate Biotechnology Co., Ltd. engages in the research, development, manufacture, production, and sale of products to prevent and treat diseases caused by viruses and bacteria in Taiwan. It provides drugs, APIs, intermediates, and release agents for the treatment of cardiovascular, esophageal, gastrointestinal, cancer, and autoimmune diseases; and controlled-release dosage forms of Western medicine, as well as cosmetics. Genovate Biotechnology Co., Ltd. was founded in 1982 and is based in Hsinchu City, Taiwan.

Recent 4130 News & Updates

Recent updates

No updates